
Lys Medical
Ultra-miniaturized endoscopic probes for lung cancer diagnosis.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
Total Funding | 000k |
Related Content
Lys Medical is a Belgian medical device company founded in 2018 as a spin-off from the Université Libre de Bruxelles. The company focuses on designing, developing, and marketing new endoscopic technologies to improve the diagnosis of lung cancer. Its primary clients are pulmonologists and gastroenterologists in hospitals.
The company's core product is the Iriscope, described as the world's smallest video-endoscopic probe. This device is designed to help physicians visually access, characterize, and biopsy hard-to-reach peripheral pulmonary nodules, which can accelerate the diagnostic pathway for lung cancer. The Iriscope aims to provide a high positive predictive value, potentially reducing the need for more invasive and costly biopsy procedures.
The business model revolves around the sale of these specialized medical devices to healthcare facilities. The development process involved extensive collaboration with medical experts, spending significant time in endoscopy units to identify the practical needs and challenges faced by practitioners. To date, Lys Medical has raised a total of $1.6 million in funding, with investors including SambrInvest and the Université Libre de Bruxelles.
Keywords: medical devices, endoscopy, lung cancer diagnosis, pulmonology, endoscopic probes, peripheral nodules, medical technology, biopsy guidance, minimally invasive, video-endoscopy